Vmax regulation through domain and subunit changes. The active form of phosphoglycerate dehydrogenase

James R. Thompson, Jessica K. Bell, Judy Bratt, Gregory A. Grant, Leonard J. Banaszak

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

An active conformation of phosphoglycerate dehydrogenase (PGDH) from Escherichia coli has been obtained using X-ray crystallography. The X-ray crystal structure is used to examine the potential intermediates for V max regulation, for the redox reaction, and for cooperative effects of serine binding. The crystal structure at 2.2 Å resolution contains bound NAD+ cofactor, either sulfate or phosphate anions, and α-ketoglutarate, a nonphysiological substrate. A PGDH subunit is formed from three distinct domains: regulatory (RBD), substrate (SBD), and nucleotide binding (NBD). The crystal conformation of the homotetramer points to the fact that, in the absence of serine, coordinated movement of the RBD-SBD domains occurs relative to the NBD. The result is a conformational change involving the steric relationships of both the domains and the subunits. Within the active site of each subunit is a bound molecule of α-ketoglutarate and the coenzyme, NAD. The catalytic or active site cleft is changed slightly although it is still solvent exposed; therefore, the catalytic reaction probably involves additional conformational changes. By comparing the inhibited with the uninhibited complex, it is possible to describe changes in conformation that are involved in the inhibitory signal transduction of serine.

Original languageEnglish (US)
Pages (from-to)5763-5773
Number of pages11
JournalBiochemistry
Volume44
Issue number15
DOIs
StatePublished - Apr 19 2005
Externally publishedYes

Fingerprint

Phosphoglycerate Dehydrogenase
Serine
Conformations
Catalytic Domain
NAD
Nucleotides
Crystal structure
Signal transduction
Redox reactions
X ray crystallography
X Ray Crystallography
Coenzymes
Substrates
Escherichia coli
Sulfates
Oxidation-Reduction
Anions
Signal Transduction
Phosphates
X-Rays

ASJC Scopus subject areas

  • Biochemistry

Cite this

Thompson, J. R., Bell, J. K., Bratt, J., Grant, G. A., & Banaszak, L. J. (2005). Vmax regulation through domain and subunit changes. The active form of phosphoglycerate dehydrogenase. Biochemistry, 44(15), 5763-5773. https://doi.org/10.1021/bi047944b

Vmax regulation through domain and subunit changes. The active form of phosphoglycerate dehydrogenase. / Thompson, James R.; Bell, Jessica K.; Bratt, Judy; Grant, Gregory A.; Banaszak, Leonard J.

In: Biochemistry, Vol. 44, No. 15, 19.04.2005, p. 5763-5773.

Research output: Contribution to journalArticle

Thompson, JR, Bell, JK, Bratt, J, Grant, GA & Banaszak, LJ 2005, 'Vmax regulation through domain and subunit changes. The active form of phosphoglycerate dehydrogenase', Biochemistry, vol. 44, no. 15, pp. 5763-5773. https://doi.org/10.1021/bi047944b
Thompson, James R. ; Bell, Jessica K. ; Bratt, Judy ; Grant, Gregory A. ; Banaszak, Leonard J. / Vmax regulation through domain and subunit changes. The active form of phosphoglycerate dehydrogenase. In: Biochemistry. 2005 ; Vol. 44, No. 15. pp. 5763-5773.
@article{fc964b2d70004924835ff4a798830cd0,
title = "Vmax regulation through domain and subunit changes. The active form of phosphoglycerate dehydrogenase",
abstract = "An active conformation of phosphoglycerate dehydrogenase (PGDH) from Escherichia coli has been obtained using X-ray crystallography. The X-ray crystal structure is used to examine the potential intermediates for V max regulation, for the redox reaction, and for cooperative effects of serine binding. The crystal structure at 2.2 {\AA} resolution contains bound NAD+ cofactor, either sulfate or phosphate anions, and α-ketoglutarate, a nonphysiological substrate. A PGDH subunit is formed from three distinct domains: regulatory (RBD), substrate (SBD), and nucleotide binding (NBD). The crystal conformation of the homotetramer points to the fact that, in the absence of serine, coordinated movement of the RBD-SBD domains occurs relative to the NBD. The result is a conformational change involving the steric relationships of both the domains and the subunits. Within the active site of each subunit is a bound molecule of α-ketoglutarate and the coenzyme, NAD. The catalytic or active site cleft is changed slightly although it is still solvent exposed; therefore, the catalytic reaction probably involves additional conformational changes. By comparing the inhibited with the uninhibited complex, it is possible to describe changes in conformation that are involved in the inhibitory signal transduction of serine.",
author = "Thompson, {James R.} and Bell, {Jessica K.} and Judy Bratt and Grant, {Gregory A.} and Banaszak, {Leonard J.}",
year = "2005",
month = "4",
day = "19",
doi = "10.1021/bi047944b",
language = "English (US)",
volume = "44",
pages = "5763--5773",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "15",

}

TY - JOUR

T1 - Vmax regulation through domain and subunit changes. The active form of phosphoglycerate dehydrogenase

AU - Thompson, James R.

AU - Bell, Jessica K.

AU - Bratt, Judy

AU - Grant, Gregory A.

AU - Banaszak, Leonard J.

PY - 2005/4/19

Y1 - 2005/4/19

N2 - An active conformation of phosphoglycerate dehydrogenase (PGDH) from Escherichia coli has been obtained using X-ray crystallography. The X-ray crystal structure is used to examine the potential intermediates for V max regulation, for the redox reaction, and for cooperative effects of serine binding. The crystal structure at 2.2 Å resolution contains bound NAD+ cofactor, either sulfate or phosphate anions, and α-ketoglutarate, a nonphysiological substrate. A PGDH subunit is formed from three distinct domains: regulatory (RBD), substrate (SBD), and nucleotide binding (NBD). The crystal conformation of the homotetramer points to the fact that, in the absence of serine, coordinated movement of the RBD-SBD domains occurs relative to the NBD. The result is a conformational change involving the steric relationships of both the domains and the subunits. Within the active site of each subunit is a bound molecule of α-ketoglutarate and the coenzyme, NAD. The catalytic or active site cleft is changed slightly although it is still solvent exposed; therefore, the catalytic reaction probably involves additional conformational changes. By comparing the inhibited with the uninhibited complex, it is possible to describe changes in conformation that are involved in the inhibitory signal transduction of serine.

AB - An active conformation of phosphoglycerate dehydrogenase (PGDH) from Escherichia coli has been obtained using X-ray crystallography. The X-ray crystal structure is used to examine the potential intermediates for V max regulation, for the redox reaction, and for cooperative effects of serine binding. The crystal structure at 2.2 Å resolution contains bound NAD+ cofactor, either sulfate or phosphate anions, and α-ketoglutarate, a nonphysiological substrate. A PGDH subunit is formed from three distinct domains: regulatory (RBD), substrate (SBD), and nucleotide binding (NBD). The crystal conformation of the homotetramer points to the fact that, in the absence of serine, coordinated movement of the RBD-SBD domains occurs relative to the NBD. The result is a conformational change involving the steric relationships of both the domains and the subunits. Within the active site of each subunit is a bound molecule of α-ketoglutarate and the coenzyme, NAD. The catalytic or active site cleft is changed slightly although it is still solvent exposed; therefore, the catalytic reaction probably involves additional conformational changes. By comparing the inhibited with the uninhibited complex, it is possible to describe changes in conformation that are involved in the inhibitory signal transduction of serine.

UR - http://www.scopus.com/inward/record.url?scp=17144364299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17144364299&partnerID=8YFLogxK

U2 - 10.1021/bi047944b

DO - 10.1021/bi047944b

M3 - Article

C2 - 15823035

AN - SCOPUS:17144364299

VL - 44

SP - 5763

EP - 5773

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 15

ER -